Entire Transcript in Adobe Acrobat Format - National Reference ...

62
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
I think what we concluded was that it would
elicit to obtain such an open ended general consent to
research in conjunction with the specific consent to the
specific research provided that that open ended referred to
future studies conducted in an anonymized manner.
Okay. So that is how that box comes about so
even though it says general what we mean is the specific
study consent plus an open ended general consent with the
opportunity there to say but not research of this nature or
not research of that, that it cannot be given to a
commercial firm, it cannot be used for whatever because you
are in a research context.
So the question about collapsing them is now
when you look at that which is collected in the clinical
context clearly there is no research protocol you are
describing. All right. The principle of if there can be
general consent to open ended studies is on the table. All
right. We think it can be. All right. We think provided
again that it is conducted in an anonymized fashion.
The question then becomes to some extent a
pragmatic question about what level of detailed and consent
one can engage in and should engage in, in the clinical
context where we have heard much discussion about being
sensitive to the patient. All right. That is the last